SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Aronex Pharma (ARNX)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
320 8 0 ARNX
Emcee:  Eduardo Canto Type:  Unmoderated
Introduction Market Data Compact
I came across ARNX about a month ago and have watched it reach above $6 on news that they were expanding phase I trials on their HIV drug. It seems that this drug is tolerated well and could be a great hit. I recently had a lecture by one of the scientists involved in developing the now famous protease inhibitors, it seems like this would be the perfect complement to the now available drugs if it does indeed have any positive effect. ARNX also has other products being tested and now have plenty of cash after having completed an offering of 6mil shares at $5. Looks promising to me. Anyone know how the trial is going?
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
320Any idea why it is moving today? HaroldHarold-8/31/2000
319 I believe I've found the answer. ama-assn.org <i>This has been the Dr. Voodoo-6/4/2000
318 Hey Sam, Whatever happened to that 'most potent Hiv integrase inhibitorDr. Voodoo-6/1/2000
317 Nice move today; Up over 30%. Hope it keeps moving. Here is the reason. NEW YNicholas Varthas-3/28/2000
316 Since it has been so quite hear, I thought I would post a link to the latest neNicholas Varthas-1/23/2000
315 Small-cap Stocks: SmallCaps Online's Recommended List is up 56% on its one BridgeTech-10/14/1999
314 Me,too,I'm Buying, <eom> ProfSam-10/13/1999
313 I to have not sold; In fact, I bought more at $3.5. I think we all need some pNicholas Varthas-10/10/1999
312 This game is not over. I have sold not a share. Maybe I am just a blind optimisSam Lee-10/9/1999
311 <<<The FDA rejects applications for substantive reasons; it's not GregSL-9/29/1999
310 >>> that there is a chance that ARNX MAY have to go back to clinical &Chris Boylan-9/29/1999
309 Deficiencies in my unmedically-qualified opinion, can be: 1. mathematical/staProfSam-9/28/1999
308 >>>>>>>>>>that there is a chance that ARNX MAY hDr. Voodoo-9/27/1999
307 Kendall, I see this as a buying opportunity. Regards, Bob The Dodgy Ticker-9/27/1999
306 the Reuter's Article quotes an analyst from the Mehta Group and somewhere ProfSam-9/27/1999
305 ARNX-very weak tape so far today, at the days low and down 20% kendall harmon-9/27/1999
304 ARNX--positive news from California << Aronex's Nyotran Anti-Fungal kendall harmon-9/26/1999
303 ARNX--from small caps online smallcapsonline.com <<Aronex Pharmaceuticakendall harmon-9/25/1999
302 ARNX--more on the Conference at which they are presenting Sunday: <<A grkendall harmon-9/25/1999
301 Ok, thanks. I note that this FDA release concerns ATRAGEN, whereas the presentkendall harmon-9/25/1999
300 I see it as favorable because of the language, "...in its current form&quoThe Dodgy Ticker-9/25/1999
299 ARNX--interesting post from physicianintexas on the YHOO thread: <i>As Ikendall harmon-9/25/1999
298 Can you say more about your interpretation of this? Why specifically do you viekendall harmon-9/25/1999
297 Aronex Pharmaceuticals Receives FDA Letter Concerning ATRAGEN September 24, 1The Dodgy Ticker-9/24/1999
296 ARNX might see buying next week ARNX ..12:47 est. Sept 24, 1999 - (Dayinvestorkendall harmon-9/24/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News